References
- Baty J. D., Price Evans D. A. “Norphenazone, a New Metabolite of Phenazone in Human Urine”. J. Pharm. Pharmacol 1973; 25: 83–84
- Fraser H. S., Bulpitt C. J., Kahn G. C., Mould G., Mucklow J. C., Dollery C. T. “Factors Affecting Antipyrine Metabolism in West African Villagers”. Clin. Pharmacol. Ther 1976; 20: 369–376
- Fraser H. S., Mucklow J. C., Murray S., Davies D. S. “Assessment of Antipyrine Kinetics by Measurement in Saliva”. Br. J. Clin. Pharmacol 1976; 3: 321–325
- Hart P., Farrell G. C., Cooksley W. G. E., Powell L. W. “Enhanced Drug Metabolism in Cigarette Smokers”. Br. Med. J. 1976; 2: 147–149
- Lindgren S., Collste P., Norlander B., Sjoqvist F. “Gas Chromatographic Assessment of the Reproducibility of Phenazone Plasma Half-Life in Young Healthy Volunteers”. Eur. J. Clin. Pharmacol 1974; 7: 381–385
- Mrochek J. E., Katz S., Christie W. H., Dinsmore S. R. “Acetaminophen Metabolism in Man as Determined by High Resolution Liquid Chromatography”. Clin. Chem 1974; 20: 1086–1096
- O'Malley K., Stevenson I. H., Crooks J. “Impairment of Human Drug Metabolism by Oral Contraceptive Steroids”. Clin. Pharmacol. Ther 1972; 13: 552–557
- Prescott L. “Gas Liquid Chromatographic Estimation of Paracetamol”. J. Pharm. Pharmacol 1971; 23: 807–808
- Vestal R. E., Norris A. H., Tobin J. D., Cohen B. H., Shock N. W., Andres R. “Antipyrine Metabolism in Man: Influence of Age, Alcohol, Caffeine and Smoking”. Clin. Pharmacol. Therap 1975; 18: 425–432
- Welch R. M., De Anglia R. L., Wingfield M., Farmer T. W. “Elimination of Antipyrine from Saliva as a Measure of Metabolism in Man”. Clin. Pharmacol. Ther 1975; 18: 249–258; 220
- Wright N., Prescott L. F. “Potentiation by Previous Drug Therapy of Hepatotoxicity Following Paracetamol Overdosage”. Scott. Med. J. 1973; 18: 56–58
- Yoshimura H., Shimeno H., Tsukamoto H. “Metabolism of Drugs. LXX. Further Study on Antipyrine Metabolism”. Chem. Pharm. Bull. (Tokyo) 1971; 19: 41–43